Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Risk stratification of patients with TP53-mutated myeloproliferative neoplasms.
Journal: Leukemia
Published: September 02, 2025
Novel strategies targeting mutant calreticulin in essential thrombocythemia and myelofibrosis.
Journal: Blood
Published: May 13, 2025
ZRSR2 loss causes aberrant splicing in JAK2V617F-driven myeloproliferative neoplasm but is not sufficient to drive disease progression.
Journal: HemaSphere
Published: February 13, 2025
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications.
Journal: Current hematologic malignancy reports
Published: December 23, 2024
Evolution of myeloproliferative neoplasms from normal blood stem cells.
Journal: Haematologica
Published: July 11, 2024
Antibody targeting of mutant calreticulin in myeloproliferative neoplasms.
Journal: Journal of cellular and molecular medicine
Published: May 27, 2023
Molecular Pathogenesis of Myeloproliferative Neoplasms.
Journal: Current hematologic malignancy reports
Published: October 10, 2022
Biology and therapeutic targeting of molecular mechanisms in MPNs.
Journal: Blood
Published: September 29, 2022
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine.
Journal: Science translational medicine
Published: June 15, 2022
Last Updated: 09/26/2026